• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home AI Roundup

Abridge drafts pediatric notes so physicians stay with the kids, not the keyboard

byDeepti Shroff
July 7, 2025
in AI Roundup
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Key points:

1. Abridge closed a $300 million Series E and launched an inpatient module integrated with Epic that speeds up note completion and reduces after-hours charting.

2. The company’s ambient AI tools are expanding rapidly, with projections for 50 million encounters this year and international expansion plans underway.

Pittsburgh start-up Abridge closed a $300 million Series E on June 24 that doubled its valuation to $5.3 billion. The funding coincided with Abridge Inside for Inpatient, an Epic-integrated module that converts bedside talk to structured notes. Sutter Health pilots show progress-note closure in under two minutes, according to the launch release. A pediatric template has earned an average 4.5-star rating across 25 000 encounters, feedback summarized in an Abridge blog. Digital Health Wire reports the platform now supports 150-plus enterprise systems and is on pace for 50 million encounters this year. The inpatient build emerged from Epic’s Workshop track, a co-development route Business Wire says cuts security review cycles by 60 percent. CEO Shiv Rao told MedCity News that a revenue-cycle copilot, now training on 12 million labeled claims, hits 98 percent first-pass acceptance in payer pilots. A HFMA session projected that even a one-point coding lift could yield hospitals $700 million over three years. Nemours Children’s reported a 32 percent drop in after-hours charting during a six-week evaluation, results shared in a JAMA Network Open preprint. User sentiment measured by KLAS Research shows a four-point net-promoter gain among Abridge adopters. Rao plans specialty templates for neonatology and oncology by Q4, expanding the addressable market 40 percent. Foley & Lardner’s health-tech brief ranks the round as the second-largest digital-scribe deal ever. International expansion talks are under way in the U.K. and Australia, where Epic penetration is rising. Ambient AI appears to be pivoting from novelty to necessity for documentation-burdened clinicians.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Machine learning models effectively screened for Parkinson’s disease using smile videos

Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial

Selective serotonin reuptake inhibitors do not affect cognitive function through breastmilk

Tags: artificial intelligencenotespediatricsscribe
Previous Post

AAV gene therapy shows durable benefit in hemophilia B

Next Post

Approved label populations may be broader than trial populations for new drugs

RelatedReports

2 Minute Medicine

Machine learning models effectively screened for Parkinson’s disease using smile videos

December 29, 2025
Parents of children with autism report greater difficulty accessing health care
Chronic Disease

Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial

December 22, 2025
Adolescent mothers in protective care more likely to have their children placed in care
Neurology

Selective serotonin reuptake inhibitors do not affect cognitive function through breastmilk

November 24, 2025
2 Minute Rewind November 29, 2021
Chronic Disease

Exposure to components of fine particulate matter is associated with risk of autism spectrum disorder

October 27, 2025
Next Post
A stethoscope intertwined with a compass

Approved label populations may be broader than trial populations for new drugs

Majority of obese tenth-graders already obese by fifth grade

Body mass index-specific waist circumference thresholds may improve mortality risk stratification in women

Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease

Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn's disease

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind January 5, 2026
  • Obstructive Sleep Apnea Risk and Mental Health Conditions Among Older Canadian Adults in the Canadian Longitudinal Study on Aging
  • Neighborhood Deprivation and Days Spent at Home After Fall-Related Hip Fracture
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.